Business Wire

Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments

Share

Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women’s health and gastroenterology. The collaboration brings together specialist expertise from Karolinska Institutet in early stage research, Rebiotix Inc. (acquired by Ferring in 2018), a late-stage clinical microbiome company, and Ferring’s therapeutic area and commercialisation capabilities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005428/en/

The extension includes six reproductive health clinical studies of approximately 6,000 women and babies and four gastroenterology studies of approximately 3,000 adults and children, to further investigate the role of the microbiome in areas of high unmet need including recurrent pregnancy loss, preterm birth and inflammatory bowel disease.

“The extension of this partnership presents an exciting research opportunity, bringing together unique capabilities of Ferring, Karolinska Institutet and Rebiotix across the clinical development continuum in the mircrobiome space,” said Lee Jones, Founder, President and Chief Executive Officer, Rebiotix, Inc. “This, together with Ferring’s significant experience in reproductive medicine and gastroenterology, offers the potential to drive future research and development for the next generation of microbiome treatments needed to help more people build healthy families and live better lives.”

Up to 5% of couples face the heartache of recurrent pregnancy loss1 and around 15 million babies are born preterm every year around the world, with approximately 1 million children dying each year due to related complications.2 Over 10 million people worldwide live with the pain and discomfort of inflammatory bowel disease.3 With reproductive health and inflammatory bowel concerns on the rise,2,4 there is a need to increase understanding of their causes and develop new solutions.

“This innovative public-private partnership demonstrates our ongoing, shared commitment to investigating the human microbiome,” said Lars Engstrand, Professor at Karolinska Institutet and Director of the Center for Translational Microbiome Research. “It will support the expansion of Karolinska Institutet’s foundation of robust biological data and drive our understanding of the microbiome’s impact on important reproductive and gut health challenges.”

ENDS

About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.

Learn more at www.ferring.com, or connect with us on Twitter, Facebook, Instagram, LinkedIn and YouTube.

About Rebiotix Inc.
Rebiotix Inc., part of the Ferring Pharmaceuticals Group, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionise the treatment of challenging diseases. Rebiotix possesses a deep and diverse clinical pipeline targeting several other disease states with drug products built on its pioneering Microbiota Restoration Therapy™ (MRT™) drug platform. The MRT platform is a standardised, stabilised drug technology that is designed to rehabilitate the human microbiome by delivering a broad consortium of live microbes into a patient’s intestinal tract via a ready-to-use and easy-to-administer format. For more information on Rebiotix and its pipeline of human microbiome-directed therapies, visit www.rebiotix.com.

About Karolinska Institutet
Karolinska Institutet is one of the world’s leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine. For more information please visit www.ki.se/en.

References:
1 Hachem HE, Crepaux V, May-Panloup P, et al. Recurrent pregnancy loss: current perspectives. International Journal of Womens Health. 2017; 9: 331–345.
2 WHO. Preterm birth. 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/preterm-birth [Accessed: January 2019].
3 Crohn’s & Colitis Foundation. World IBD Day: Beyond Borders May 19, 2018. Available at: http://www.crohnscolitisfoundation.org/WorldIBDDay/ [Accessed: January 2019].
4 Kaplan G. The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology & Hepatology. 2015; 12: 720–727.

Contact information

Lindsey Rodger
Senior Manager, Corporate Communications
+41 58 451 40 23 (direct)
+41 79 191 04 86 (mobile)
lindsey.rodger@ferring.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Bending Spoons Launches Playond: the Mobile Gaming Service for Everybody15.11.2019 13:30:00 EETPress release

Bending Spoons, Europe’s number one iOS mobile app developer, has officially launched Playond. This new gaming service gives members unlimited access to an ever-growing catalog of critically acclaimed premium games. The current collection of 60+ games is now available to everybody: Users can play for free with some limitations, or subscribe for an early bird price of $0.99/month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191115005141/en/ (Photo: Bending Spoons) “We are thrilled to have partnered with some of the most dedicated game developers and indie studios in the world. Playond is a service created by mobile gamers, for mobile gamers: our mission is bringing premium games on the App Store to as many players as possible, ultimately leveling-up the mobile gaming experience we can all enjoy" says Mauro Bolis, Project Manager of Playond. In recent years, free-to-play games designed to maximize ad impressions and in-app

Boyaa Poker Tournament Europe 2019. Ticketing Final Countdown15.11.2019 13:18:00 EETPress release

Boyaa Poker Tournament Europe 2019 will take place from December 5 to 8 at King's Resort with a guaranteed prize of € 200,000. If you want a ticket, hurry up because the final countdown is ticking. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191115005139/en/ (Photo: Business Wire) An Asian experience recommended by European players Boyaa Interactive (Stock code 0434.HK) organized the first BPT in 2015 as a way to enrich its online social poker game and to reach its users worldwide, particularly in Southeast Asia. Now, this BPT comes to Europe for its sixth edition with an interesting proposal that includes a more cheerful and modern image than usual poker tournaments, side events with different buy-ins levels, and flashy trophies for the winners. Some European poker players that participated in previous BPT editions highlighted the diversity of countries that are usually represented in the BPT tournaments, and how the hos

Hagiwara Solutions to Exhibit at SPS 201915.11.2019 12:00:00 EETPress release

Hagiwara Solutions Co., Ltd. (Elecom group) will exhibit at sps – smart production solution from the 26th to 28th of November 2019, Trade Fair Nuremberg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191115005082/en/ Introduction Map (Graphic: Hagiwara Solutions) Hagiwara Solutions Co., Ltd. is with Elecom group which is offering solutions with sensing technologies, industrial computers, and SSDs. D-Clue Technologies Co., Ltd. of Elecom group which is good for sensing technologies will join us at sps. SEVEN solutions for your own: Coolant Contamination Detection: How do you manage machine tool coolant for precise products? You can maintain the coolant correctly, using our live sensing system. Let us suggest you make precise products with our coolant contamination detection system. AR Goggle Devices: How do you browse reference documents during your tasks? Workers with our AR goggles don’t need to worry about it. The AR gogg

At CIIE 2019 Panasonic Showcases Solutions to Help Bring to Life China's "Healthy China 2030" Vision15.11.2019 07:22:00 EETPress release

Panasonic Corporation took part in the 2nd China International Import Expo (CIIE) 2019, which was held in Shanghai from November 5 to 10. Under the theme, "Limitless Care for Healthy Living," Panasonic showcased health and welfare products and solutions that reflect its unique health values. With these products and solutions for a healthy life and aging society, Panasonic aspires to help bring to life China's "Healthy China 2030" vision. Panasonic also introduced its cutting-edge technologies that contribute to the business scene. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005958/en/ Panasonic booth at CIIE 2019 (Photo: Business Wire) [Video] #CIIE 2019 Panasonic Highlights - The 2nd China International Import Expo https://youtu.be/CbvZClNirQc Panasonic Booth Highlights Solutions for a Healthy Life and an Aging Society 1. "Healthy Environment Unit" With the evolution of sensing and data analytics technology, spaces

Alibaba Group Launches Hong Kong Initial Public Offering15.11.2019 01:47:00 EETPress release

Alibaba Group Holding Limited (NYSE: BABA) (“Alibaba” or “the Company”) today announced the launch of its Hong Kong public offering (the “Public Retail Offering”), which forms part of the global offering (the “Offering”) of 500,000,000 new ordinary shares (the “Shares”) and listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “SEHK”) under the stock code “9988.” The Company’s American depositary shares (“ADSs”), each representing eight ordinary shares of the Company, will continue to be listed and traded on the New York Stock Exchange (“NYSE”). Upon listing in Hong Kong, the Hong Kong-listed shares will be fully fungible with the ADSs listed on the NYSE. “Alibaba is guided by our mission to make it easy to do business anywhere with the vision to be a good company that lasts for 102 years. We aim to serve global consumers, of which more than 1 billion will be Chinese consumers, and facilitate more than RMB10 trillion of consumption on our plat

ABI Research Names PTC a Leader in Enterprise Augmented Reality Platforms14.11.2019 22:05:00 EETPress release

PTC (NASDAQ: PTC) today announced it has been named a leader in the Enterprise Augmented Reality Platforms market for its Vuforia® augmented reality (AR) solution suite in a new research report from ABI Research entitled, “Competitive Assessment – Enterprise Augmented Reality Platforms.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005759/en/ ABI Research Names PTC a Leader in Enterprise Augmented Reality Platforms (Graphic: Business Wire) The ABI Research report evaluated vendors on two criteria – innovation and implementation. ABI Research ranked Vuforia first in the innovation category due to PTC’s expansive customer and partner footprint, its advancements in transformative technology and functionality, and the company’s robust digital thread capability. In the implementation category, the ABI Research report highlighted Vuforia’s strength in device support, as well as “options from low-level development tools up

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom